These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6892440)

  • 1. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
    Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
    Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
    [No Abstract]   [Full Text] [Related]  

  • 2. [Duration of effects of isosorbide dinitrate retard in coronary disease].
    Raab C; Schindler J; Rahlfs VW
    Med Welt; 1977 Nov; 28(44):1807-9. PubMed ID: 593121
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
    Joseph G
    Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of nitro-retard preparations during rest and ergometric exercise in patients with coronary heart disease].
    Boutefeu JM; Righetti A; Rutishauser W
    Med Welt; 1980 Aug; 31(35):1251-4. PubMed ID: 7421560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ergometric evaluation of the efficacy of a delayed-action nitroderivative].
    Vajola SF; Boccardi L; Cacciatore G; Minardi G; Pozzar F; Schiavo B
    Boll Soc Ital Cardiol; 1981; 26(11):1417-20. PubMed ID: 7349184
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of 2 recent isosorbide dinitrate preparations as new long-term galenicals with commonly used delayed-action preparations].
    Hagel H
    ZFA (Stuttgart); 1984 Jan; 60(1):40-3. PubMed ID: 6711082
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the effects of depot peroral and transdermal administration of nitrate preparations].
    Camek R; Karetová D; Bultas J; Krupicka P; Boudĭk F; Fabian E
    Vnitr Lek; 1988 Feb; 34(2):122-9. PubMed ID: 3129873
    [No Abstract]   [Full Text] [Related]  

  • 10. [The procedure for antianginal therapy with Isoket and nitrosorbide].
    Zhiliaev EV; Glazunov AV; Koroba GS
    Ter Arkh; 1992; 64(8):9-13. PubMed ID: 1440407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the therapeutic efficacy of 4 different delayed-action nitro-derivatives on S-T changes after exercise tests].
    Roncarolo PL; Falcone M; Gabasio C; Aletto C; Guasone V; Allegri M; Giordano MP
    Minerva Cardioangiol; 1978 Sep; 26(9):615-8. PubMed ID: 100745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disparate efficacy of isosorbide dinitrate, in sustained-release form, during acute and chronic administration (author's transl)].
    Blasini R; Brügmann U; Mannes A; Froer KL; Hall D; Rudolph W
    Herz; 1980 Oct; 5(5):298-305. PubMed ID: 7450664
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the exercise test for determining the optimal dose of prolonged-action nitrates in patients with angina pectoris].
    Martsevich SIu; Vygodin VA; Metelitsa VI
    Ter Arkh; 1981; 53(12):22-6. PubMed ID: 7347239
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate.
    Bogaert MG; Rosseel MT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2424-7. PubMed ID: 7422532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iso Mack Retard 40 mg. Coronary drug for long term therapy and prophylaxis in coronary circulation disorders (angina pectoris)].
    Wien Klin Wochenschr; 1980 Oct; 92(19):695-6. PubMed ID: 7467343
    [No Abstract]   [Full Text] [Related]  

  • 19. What constitutes adequate medical therapy for the patient with angina pectoris?
    Russek HI
    Geriatrics; 1974 Apr; 29(4):109-12 passim. PubMed ID: 4206865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.